Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
306
-
Total 13F shares, excl. options
-
66.2M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$7.13B
-
Value change
-
+$112M
-
Put/Call ratio
-
0.57
-
Number of buys
-
161
-
Number of sells
-
-121
-
Price
-
$107.78
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2024
362 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2024.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.2M shares
.
Largest 10 shareholders include BlackRock Inc. (6.65M shares), VANGUARD GROUP INC (6.54M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.87M shares), FMR LLC (4.83M shares), WELLINGTON MANAGEMENT GROUP LLP (3.24M shares), Rock Springs Capital Management LP (2.46M shares), STATE STREET CORP (2.38M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.59M shares), GEODE CAPITAL MANAGEMENT, LLC (1.46M shares), and MACQUARIE GROUP LTD (1.31M shares).
This table shows the top 306 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.